Hereditary breast cancer next‐generation sequencing panel evaluation in the south region of Brazil: A novel BRCA2 candidate pathogenic variant is reported
Molecular Genetics & Genomic Medicine · 2024
DOI: 10.1002/mgg3.2504 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Cesar Augusto B Duarte und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development Division, Genoprimer Diagnóstico Molecular, Curitiba, Paraná, Brazil. Hauptthemen laut MEDLINE: BRCA2 Protein, Breast Neoplasms, Checkpoint Kinase 2, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: None..
Abstract (Originalsprache)
Background
In this article, we delineate a loosely selected cohort comprising patients with a history of early‐onset breast cancer and/or a familial occurrence of cancer. The aim of this study was to gain insights into the presence of breast cancer‐related gene variants in a population from a micro‐region in southern Brazil, specifically the Metropolitan Region of Curitiba. This area exhibits a highly genetically mixed population, mirroring the general characteristics of the Brazilian people.
Methods
Comprehensive next‐generation sequencing (NGS) multigene panel testing was conducted on 12 patients from the region, utilizing three different library preparation methods.
Results
Two pathogenic variants and one candidate pathogenic variant were identified: BRCA2 c.8878C>T, p.Gln2960Ter; CHEK2 c.1100del, p.Thr367Metfs15, and BRCA2 c.3482dup, p.Asp1161Glufs3.
Conclusion
BRCA2 c.3482dup, a novel candidate pathogenic variant, previously unpublished, is reported. The prevalence of pathogenic variants in this small cohort is similar to that described in the literature. All different library preparation methods were equally proficient in enabling the detection of these variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research and Development Division, Genoprimer Diagnóstico Molecular, Curitiba, Paraná, Brazil.
- Molecular Biology Clinical Laboratory, Clinimol Diagnóstico Molecular, São Paulo, São Paulo, Brazil.
- Department of Surgery, Hospital Nossa Senhora das Graças, Curitiba, Paraná, Brazil.
ORCID-Profile: Cesar Augusto B Duarte
Förderung
- None.
Zitieren
APA
Duarte, C. A. B., Dos Santos, C. A., de Oliveira, C. D. D., Spautz, C. C., Sumita, L. M., & Nakatani, S. M. (2024). Hereditary breast cancer next‐generation sequencing panel evaluation in the south region of Brazil: A novel BRCA2 candidate pathogenic variant is reported. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2504
Vancouver
Duarte CAB, Dos Santos CA, de Oliveira CDD, Spautz CC, Sumita LM, Nakatani SM. Hereditary breast cancer next‐generation sequencing panel evaluation in the south region of Brazil: A novel BRCA2 candidate pathogenic variant is reported. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.2504
BibTeX
@article{Duarte2024,
author = {Duarte, Cesar Augusto B and Dos Santos, Carlos Alberto and de Oliveira, Cristine Domingues D and Spautz, Cleverton César and Sumita, Laura Masami and Nakatani, Sueli Massumi},
title = {Hereditary breast cancer next‐generation sequencing panel evaluation in the south region of Brazil: A novel BRCA2 candidate pathogenic variant is reported},
journal = {Molecular Genetics & Genomic Medicine},
year = {2024},
doi = {10.1002/mgg3.2504}
}
EUVIMED